The Interrelationship Between Andropause Symptoms, Testosterone Levels, and Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia (BPH): A Cross-Sectional Study.

Introduction This study aimed to assess the prevalence of andropause symptoms and testosterone levels in male patients with symptomatic benign prostatic hyperplasia (BPH), as well as to explore the relationship between these factors. Methods A total of 183 male patients aged 50 years and older with diagnosed lower urinary tract symptoms (LUTS) due to BPH were included. Andropause symptoms were evaluated using the Male Andropause Symptoms Self-Assessment Questionnaire (MASSQ), while testosterone levels were measured using a chemiluminescent immunoassay.

Complications of Semirigid Ureteroscopy in Ureteric Stone Treatment.

Introduction Ureteroscopy (URS) is a minimally invasive endoscopic technique commonly used to manage ureteric stones. This study prospectively reports and grades the complications associated with semirigid URS for ureteric stone removal and aims to identify factors contributing to these complications. Methods Prospective data were collected from 160 consecutive patients who underwent semirigid URS for ureteric stones at a single center between June 2021 and December 2022.

Association Between Erectile Dysfunction and Lower Urinary Tract Symptoms in a North Indian Tertiary Care Hospital.

Introduction This study aimed to investigate the relationship between erectile dysfunction (ED) and lower urinary tract symptoms (LUTS) in a North Indian population, as well as to assess the influence of age, serum prostate-specific antigen (PSA), and testosterone levels on this association. Materials and methods A cross-sectional study was conducted at King George's Medical University, Lucknow, India, involving 183 men aged ≥50 years presenting with LUTS or benign prostatic hyperplasia (BPH). The severity of ED was assessed using the International Index of Erectile Function-15 (IIEF-15), while LUTS severity was measured using the International Prostate Symptom Score (IPSS).

The current status of miRNA in urinary bladder cancer: A minireview and strength, weakness, opportunity, and threat analysis.

MicroRNAs, small noncoding RNA molecules, are critical in modulating gene expression and contribute substantially to the initiation and progression of urinary bladder cancer (UBCa), a major malignancy affecting people globally. UBCa is known for its high recurrence rates and significant heterogeneity. The stability of miRNAs in body fluids such as urine and blood are excellent potential noninvasive markers for early detection, monitoring treatment progress, and predicting outcomes of patients with UBCa.